Redefining Liver Fibrosis Risk Assessment in Indians with Type 2 Diabetes: New FIB-4 Score Cutoff fo...
Redefining Liver Fibrosis Risk Assessment in Indians with Type 2 Diabetes: New FIB-4 Score Cutoff for Optimizing Sequential Assessment with Transient Elastography
About this item
Full title
Author / Creator
Publisher
India: Wolters Kluwer - Medknow
Journal title
Language
English
Formats
Publication information
Publisher
India: Wolters Kluwer - Medknow
Subjects
More information
Scope and Contents
Contents
Abstract
Introduction:
Liver fibrosis in metabolic dysfunction-associated steatotic liver disease (MASLD) is strongly related to hepatic and extrahepatic outcomes. Clinically Significant Liver Fibrosis (CSLF) screening using FIB-4 score is mandated in all T2D patients. The existing FIB-4 cutoff of 1.3 is derived from Western studies and could...
Alternative Titles
Full title
Redefining Liver Fibrosis Risk Assessment in Indians with Type 2 Diabetes: New FIB-4 Score Cutoff for Optimizing Sequential Assessment with Transient Elastography
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_c6e0b11f21d0467e9078cb9e4616c7d0
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c6e0b11f21d0467e9078cb9e4616c7d0
Other Identifiers
ISSN
2230-8210
E-ISSN
2230-9500
DOI
10.4103/ijem.ijem_457_24
